Clinical trial
Safety of Vascugel Treatment After Creation of Arteriovenous Access for…
NCT00479180 · Pervasis Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00479180 |
|---|---|
| Title | Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use |
| Official title | Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use |
| Lead sponsor | Pervasis Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hemodialysis Access |
| Intervention type | Biological |
| Interventions | Vascugel, Placebo Comparator |
| Enrollment | 65 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | May 28, 2007 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: